Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 267-273

  Lee, Jeong A ^a,b   Kang, Cheol In ^a   Joo, Eun Jeong ^a   Ha, Young Eun ^a   Kang, Seung Ji ^a   Park, So Yeon ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Ko, Kwan Soo ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a  

^a Sungkyunkwan University   (South Korea)

^b Konyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CORTICOSTEROID; EXTENDED SPECTRUM BETA LACTAMASE;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY ONSET BACTEREMIA; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FEMALE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL DIVERSITY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TUBE;

ADMINISTRATION, CUTANEOUS; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CROSS INFECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; NEOPLASMS; PHYLOGENY; REPUBLIC OF KOREA; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

KLEBSIELLA PNEUMONIAE;

EID: 79957667888     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0134     Document Type: Article

References (25)

1. Arpin, C., V. Dubois, L. Coulange, C. Andre, I. Fischer, P. Noury, F. Grobost, J.P. Brochet, J. Jullin, B. Dutilh, G. Larribet, I. Lagrange, and C. Quentin. 2003. Extendedspectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob. Agents Chemother. 47:3506-3514. (Pubitemid 37345711)
2. Azap, O.K., H. Arslan, K. Serefhanoglu, S. Colakoglu, H. Erdogan, F. Timurkaynak, and S.S. Senger. 2009. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin. Microbiol. Infect. 16:147-151.
3. Ben-Ami, R., J. Rodriguez-Bano, H. Arslan, J.D. Pitout, C. Quentin, E.S. Calbo, O.K. Azap, C. Arpin, A. Pascual, D.M. Livermore, J. Garau, and Y. Carmeli. 2009. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 49:682-690.
4. Calbo, E., V. Romani, M. Xercavins, L. Gomez, C.G. Vidal, S. Quintana, J. Vila, and J. Garau. 2006. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 57:780-783.
5. Chung, D.R., H.R. Lee, S.S. Lee, S.W. Kim, H.H. Chang, S.I. Jung, M.D. Oh, K.S. Ko, C.I. Kang, K.R. Peck, and J.H. Song. 2008. Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea. J. Clin. Microbiol. 46:4061-4063.
6. Colodner, R., W. Rock, B. Chazan, N. Keller, N. Guy, W. Sakran, and R. Raz. 2004. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 23:163-167. (Pubitemid 38471420)
7. Diekema, D.J., S.E. Beekmann, K.C. Chapin, K.A. Morel, E. Munson, and G.V. Doern. 2003. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J. Clin. Microbiol. 41:3655-3660. (Pubitemid 36994698)
8. Friedman, N.D., K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, J.P. Briggs, W. Lamm, C. Clark, J. MacFarquhar, A.L. Walton, L.B. Reller, and D.J. Sexton. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791-797. (Pubitemid 35334450)
9. Kang, C.I., H.S. Cheong, D.R. Chung, K.R. Peck, J.H. Song, M.D. Oh, and K.W. Choe. 2008. Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur. J. Clin. Microbiol. Infect. Dis. 27:85-88. (Pubitemid 350197875)
10. Kang, C.I., S.H. Kim, D.M. Kim, W.B. Park, K.D. Lee, H.B. Kim, M.D. Oh, E.C. Kim, and K.W. Choe. 2004. Risk factors for ciprofloxacin resistance in bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb. Drug Resist. 10:71-76. (Pubitemid 38529720)
11. Kang, C.I., J.H. Song, D.R. Chung, K.R. Peck, K.S. Ko, J.S. Yeom, H.K. Ki, J.S. Son, S.S. Lee, Y.S. Kim, S.I. Jung, S.W. Kim, H.H. Chang, S.Y. Ryu, K.T. Kwon, H. Lee, C. Moon, and S.Y. Shin. 2010. Risk factors and treatment outcomes of community-onset bacteraemia caused by extendedspectrum beta-lactamase-producing Escherichia coli. Int. J. Antimicrob. Agents 36:284-287.
12. Keynan, Y., and E. Rubinstein. 2007. The changing face of Klebsiella pneumoniae infections in the community. Int. J. Antimicrob. Agents 30:385-389. (Pubitemid 47498960)
13. Kim, J., Y.M. Lim, I. Rheem, Y. Lee, J.C. Lee, S.Y. Seol, Y.C. Lee, and D.T. Cho. 2005. CTX-M and SHV-12 betalactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol. Lett. 245:93-98. (Pubitemid 40410682)
14. Luzzaro, F., M. Mezzatesta, C. Mugnaioli, M. Perilli, S. Stefani, G. Amicosante, G.M. Rossolini, and A. Toniolo. Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J. Clin. Microbiol. 44:1659-1664.
15. Paterson, D.L., and R.A. Bonomo. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
16. Pitout, J.D., N.D. Hanson, D.L. Church, and K.B. Laupland. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin. Infect. Dis. 38:1736-1741.
17. Pitout, J.D., P. Nordmann, K.B. Laupland, and L. Poirel. Emergence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59.
18. Rodriguez-Bano, J., J.C. Alcala, J.M. Cisneros, F. Grill, A. Oliver, J.P. Horcajada, T. Tortola, B. Mirelis, G. Navarro, M. Cuenca, M. Esteve, C. Pena, A.C. Llanos, R. Canton, and A. Pascual. 2008. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch. Intern. Med. 168:1897-1902.
19. Rodriguez-Bano, J., M.D. Navarro, L. Romero, L. Martinez-Martinez, M.A. Muniain, E.J. Perea, R. Perez-Cano, and A. Pascual. 2004. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase- producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089-1094. (Pubitemid 38332830)
20. Rodriguez-Bano, J., and D.L. Paterson. 2006. A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin. Infect. Dis. 42:935-937.
21. Rodriguez-Bano, J., E. Picon, P. Gijon, J.R. Hernandez, M. Ruiz, C. Pena, M. Almela, B. Almirante, F. Grill, J. Colomina, M. Gimenez, A. Oliver, J.P. Horcajada, G. Navarro, A. Coloma, and A. Pascual. 2010. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin. Infect. Dis. 50:40-48.
22. Schwaber, M.J., S. Navon-Venezia, D. Schwartz, and Y. Carmeli. 2005. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase- producing Enterobacteriaceae. Antimicrob. Agents Chemother. 49: 2137-2139. (Pubitemid 40631641)
23. Soge, O.O., A.M. Queenan, K.K. Ojo, B.A. Adeniyi, and M.C. Roberts. 2006. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae. J. Antimicrob. Chemother. 57:24-30. (Pubitemid 43057055)
24. Trecarichi, E.M., M. Tumbarello, T. Spanu, M. Caira, L. Fianchi, P. Chiusolo, G. Fadda, G. Leone, R. Cauda, and L. Pagano. 2009. Incidence and clinical impact of extendedspectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J. Infect. 58:299-307.
25. Tumbarello, M., T. Spanu, M. Sanguinetti, R. Citton, E. Montuori, F. Leone, G. Fadda, and R. Cauda. 2006. Bloodstream infections caused by extended-spectrum-betalactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob. Agents Chemother. 50:498-504. (Pubitemid 43190958)